Cargando…
Peroxidase is a novel potential marker in glioblastoma through bioinformatics method and experimental validation
Peroxidase (PXDN), a specific extracellular matrix (ECM)-associated protein, has been determined as a tumor indicator and therapeutic target in various tumors. However, the effects of PXDN in prognostic performance and clinical implications in glioblastoma multiforme (GBM) remains unknown. Here, we...
Autores principales: | Shi, Weiwei, Ding, Wenjie, Zhao, Zixuan, Wang, Rui, Wang, Fengxu, Tang, Yanfen, Zhu, Jinfeng, Su, Chengcheng, Zhao, Xinyuan, Liu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471987/ https://www.ncbi.nlm.nih.gov/pubmed/36118855 http://dx.doi.org/10.3389/fgene.2022.990344 |
Ejemplares similares
-
Identification of a Gene Signature of Cancer-Associated Fibroblasts to Predict Prognosis in Ovarian Cancer
por: Zeng, Li, et al.
Publicado: (2022) -
Comprehensive analysis of PTPN gene family revealing PTPN7 as a novel biomarker for immuno-hot tumors in breast cancer
por: Wang, Fengxu, et al.
Publicado: (2022) -
Identification and Validation of Potential Pathogenic Genes and Prognostic Markers in ESCC by Integrated Bioinformatics Analysis
por: Tang, Lu, et al.
Publicado: (2020) -
Identification of BST2 Contributing to the Development of Glioblastoma Based on Bioinformatics Analysis
por: Kong, Yang, et al.
Publicado: (2022) -
Identification of novel biomarkers in septic cardiomyopathy via integrated bioinformatics analysis and experimental validation
por: Lu, Feng, et al.
Publicado: (2022)